McKinsey June 11, 2024
Medtech companies can achieve above-market growth and margin expansion by upping their ‘Commercial Quotient’ through investing in basic, omnichannel, and ecosystem selling capabilities.
Since 2020, the medtech industry has struggled with low growth rates compared to the eight preceding years. Although growth began to return to prepandemic levels in 2023, medtech companies still struggle to understand how to accelerate and sustain growth.
Based on research with more than 60 medtech companies, McKinsey analysis suggests that commercial capabilities are a strong predictor of growth. Companies with...
Today's Sponsors
Today's Sponsor
Topics: Medical Devices